Lira smiled, brittle but honest. She told the story in half-sighs and whole silences: the merc raid, the misrouted freight, the cargo hold that shouldn’t have been empty. She’d been hidden inside a crate for days, traded from hand to hand, until she’d finally slipped loose in a place that smelled of salt and old diesel. Her captors had left her with a number: JUQ-565. It was supposed to be a warning. A brand. A promise that the Runner would be next.
Tumor biopsies harvested 4 h after the first dose were analyzed for p‑Akt and γ‑H2AX (DNA damage marker) by immunohistochemistry. JUQ-565
Mara tightened her gloves. She’d spent the months since pulling wires, swapping capacitors, and begging favors from vendors who still remembered how she paid debts—mostly with stubbornness and the ability to find things other people thought lost. Tonight she had a manifest of a different kind: a single name, stamped in faded ink and clipped to a scrap of a contract nobody wanted to touch. Lira Voss. Missing. An unpaid debt to a friend who’d died whispering that name like a prayer. Lira smiled, brittle but honest
JUQ‑565, PI3Kα inhibitor, triple‑negative breast cancer, targeted therapy, structure‑activity relationship, oral bioavailability Her captors had left her with a number: JUQ-565